4
Changes in Ownership
Jasper Therapeutics, Inc. Filed Acc 0001213900-22-014572
Options or other derivatives
- President, CEO and Director acquired 1,704,328 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
MARTELL RON · President, CEO and Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-03-21 | Grant or award : show line 1 in the form Stock Option (right to buy) | +1,704,328 | 1,704,328 | D |
Loading xslF345X03/ownership.xml…